235 related articles for article (PubMed ID: 16337831)
21. Comparison of vaccine strategies against congenital CMV infection in the guinea pig model.
Schleiss MR
J Clin Virol; 2008 Mar; 41(3):224-30. PubMed ID: 18060834
[TBL] [Abstract][Full Text] [Related]
22. Acquisition of human cytomegalovirus infection in infants via breast milk: natural immunization or cause for concern?
Schleiss MR
Rev Med Virol; 2006; 16(2):73-82. PubMed ID: 16287195
[TBL] [Abstract][Full Text] [Related]
23. Detection of human cytomegalovirus-specific T lymphocytes in human blood: comparison of two methods.
Schermann CM; Fischer G; Witt V; Kurz M; Potschger U; Fritsch G
Cytotherapy; 2008; 10(8):834-41. PubMed ID: 19016371
[TBL] [Abstract][Full Text] [Related]
24. Monitoring human cytomegalovirus infection in transplant recipients.
Baldanti F; Lilleri D; Gerna G
J Clin Virol; 2008 Mar; 41(3):237-41. PubMed ID: 18203657
[TBL] [Abstract][Full Text] [Related]
25. Cytomegalovirus Vaccines: Current Status and Future Prospects.
Anderholm KM; Bierle CJ; Schleiss MR
Drugs; 2016 Nov; 76(17):1625-1645. PubMed ID: 27882457
[TBL] [Abstract][Full Text] [Related]
26. Prevention of cytomegalovirus disease by Towne strain live attenuated vaccine.
Plotkin SA; Smiley ML; Friedman HM; Starr SE; Fleisher GR; Wlodaver C; Dafoe DC; Friedman AD; Grossman RA; Barker CF
Birth Defects Orig Artic Ser; 1984; 20(1):271-87. PubMed ID: 6329367
[No Abstract] [Full Text] [Related]
27. Lymphoproliferative response in primary human cytomegalovirus (HCMV) infection is delayed in HCMV transmitter mothers.
Revello MG; Lilleri D; Zavattoni M; Furione M; Genini E; Comolli G; Gerna G
J Infect Dis; 2006 Jan; 193(2):269-76. PubMed ID: 16362891
[TBL] [Abstract][Full Text] [Related]
28. Clinical aspects and management of cytomegalovirus infection.
Sissons JG; Carmichael AJ
J Infect; 2002 Feb; 44(2):78-83. PubMed ID: 12076065
[TBL] [Abstract][Full Text] [Related]
29. Cytomegalovirus and varicella-zoster virus vaccines in hematopoietic stem cell transplantation.
Herr W; Plachter B
Expert Rev Vaccines; 2009 Aug; 8(8):999-1021. PubMed ID: 19627184
[TBL] [Abstract][Full Text] [Related]
30. Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection.
Wang Z; La Rosa C; Lacey SF; Maas R; Mekhoubad S; Britt WJ; Diamond DJ
J Clin Virol; 2006 Mar; 35(3):324-31. PubMed ID: 16388983
[TBL] [Abstract][Full Text] [Related]
31. Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age.
Adler SP; Starr SE; Plotkin SA; Hempfling SH; Buis J; Manning ML; Best AM
J Infect Dis; 1995 Jan; 171(1):26-32. PubMed ID: 7798679
[TBL] [Abstract][Full Text] [Related]
32. A proviral role for CpG in cytomegalovirus infection.
Iversen AC; Steinkjer B; Nilsen N; Bohnhorst J; Moen SH; Vik R; Stephens P; Thomas DW; Benedict CA; Espevik T
J Immunol; 2009 May; 182(9):5672-81. PubMed ID: 19380814
[TBL] [Abstract][Full Text] [Related]
33. Progress toward an elusive goal: current status of cytomegalovirus vaccines.
Schleiss MR; Heineman TC
Expert Rev Vaccines; 2005 Jun; 4(3):381-406. PubMed ID: 16026251
[TBL] [Abstract][Full Text] [Related]
34. Human cytomegalovirus-specific memory CD8+ and CD4+ T cell differentiation after primary infection.
Lilleri D; Fornara C; Revello MG; Gerna G
J Infect Dis; 2008 Aug; 198(4):536-43. PubMed ID: 18590456
[TBL] [Abstract][Full Text] [Related]
35. Cellular immunotherapy for viral infection after HSC transplantation.
Moss P; Rickinson A
Nat Rev Immunol; 2005 Jan; 5(1):9-20. PubMed ID: 15630425
[TBL] [Abstract][Full Text] [Related]
36. Human cytomegalovirus salivary antibodies as related to stress.
Sarid O; Anson O; Yaari A; Margalith M
Clin Lab; 2002; 48(5-6):297-305. PubMed ID: 12071580
[TBL] [Abstract][Full Text] [Related]
37. Recent approaches and strategies in the generation of antihuman cytomegalovirus vaccines.
Boppana SB; Britt WJ
Methods Mol Biol; 2014; 1119():311-48. PubMed ID: 24639230
[TBL] [Abstract][Full Text] [Related]
38. Control of human cytomegalovirus infection in patients infected with human immunodeficiency virus by high levels of specific CD8+ T-cells.
Lilleri D; Chiesa A; Fornara C; Maserati R; Lozza L; Comolli G; Gerna G
Clin Microbiol Infect; 2007 Jan; 13(1):19-24. PubMed ID: 17184283
[TBL] [Abstract][Full Text] [Related]
39. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection.
Bekker V; Scherpbier H; Pajkrt D; Jurriaans S; Zaaijer H; Kuijpers TW
Pediatrics; 2006 Aug; 118(2):e315-22. PubMed ID: 16847077
[TBL] [Abstract][Full Text] [Related]
40. Modulation of HLA expression in human cytomegalovirus immune evasion.
Lin A; Xu H; Yan W
Cell Mol Immunol; 2007 Apr; 4(2):91-8. PubMed ID: 17484802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
